Top Beauty and Cosmetics Stocks in Focus Right Now
Beauty and Cosmetics stocks like NUS, ULTA and SBH are thriving on innovation, digital engagement and strategic expansions.
Is Nu Skin Enterprises (NUS) Outperforming Other Consumer Staples Stocks This Year?
Here is how Nu Skin Enterprises (NUS) and Primo Brands (PRMB) have performed compared to their sector so far this year.
Nu Skin Q4 Earnings Beat Estimates, Rhyz Revenues Increase Y/Y
NUS Q4 results reflect lower revenues and higher earnings. The adjusted operating margin expands 130 bps y/y.
Nu Skin Enterprises, Inc. (NUS) Q4 2024 Earnings Call Transcript
Nu Skin Enterprises, Inc. (NYSE:NUS ) Q4 2024 Earnings Conference Call February 13, 2025 5:00 PM ET Company Participants B.G. Hunt - Head of Investor Relations Ryan Napierski - President & Chief Executive Officer James Thomas - Chief Financial Officer Conference Call Participants Sydney Wagner - Jefferies Christina Xue - D.A.
Nu Skin Enterprises (NUS) Q4 Earnings and Revenues Top Estimates
Nu Skin Enterprises (NUS) came out with quarterly earnings of $0.38 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.37 per share a year ago.
Nu Skin Gears Up for Q4 Earnings: What Surprise Awaits Investors?
NUS' fourth-quarter 2024 results are likely to show the impacts of a tough operating backdrop and pressures within the direct selling industry.
Analysts Estimate Nu Skin Enterprises (NUS) to Report a Decline in Earnings: What to Look Out for
Nu Skin (NUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NUS Q4 Preliminary Revenues Reach Top End of Outlook, Stock Gains 9.8%
Nu Skin's shares rally as the company stated that its preliminary revenues for Q4 came in at the upper end of its projected range.
Nu Skin: New Cash From Mavely's Sale Could Accelerate Inorganic Growth
Nu Skin Enterprises sold its Mavely affiliate marketing platform for $250 million, achieving a 5x ROI since 2021, and plans to use the cash for debt reduction and innovation. The new cash influx could accelerate both inorganic and organic growth, with potential acquisitions enhancing revenue and free cash flow growth. NUS could benefit from potential tax reductions under the new U.S. administration, which may increase net income and stock demand.
What Does Nu Skin's Mavely Sale Mean for Its Long-Term Strategy?
NUS' subsidiary has sold its Mavely affiliate marketing platform to Later for nearly $250 million, boosting innovation and resources.
Nu Skin generated about five-times return on Mavely investment, says Jefferies
After Nu Skin announced the sale of its marketing tech platform business, Mavely, to Summit Partners portfolio company Later, Jefferies noted that this transaction generated about a five-times return on company's investment in Mavely since the acquisition in 2021. Nu Skin's Q3 sales softness was offset by strength from the Rhyz business, with strength led by Mavely, noted the analyst, who also points out that the company will have a minority stake in the Later and Mavely combined businesses. Jefferies has a Hold rating and $7 price target on Nu Skin shares.
Nu Skin Stock Sinks 40% in Six Months: Hold Steady or Time to Exit?
Nu Skin is struggling with a difficult macroeconomic landscape, volatile currency movements and pressures in the direct selling industry.
